---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-064883"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:49:50.142361+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TriSalus launches warrant exchange offer at 0.3 shares per warrant; seeks to reduce dilution

## Summary
- Offering up to 4,264,532 common shares for up to 14.2M warrants (0.30 per warrant).
- 34.8% of Public Warrants pre-committed; needs ~15.3% more to meet majority threshold.
- Consent solicitation seeks amendment allowing forced conversion at 0.27 shares (10% discount).
- Expiration date: June 25, 2024; Oppenheimer & Co. is dealer manager.
- Company aims to simplify capital structure and reduce future dilutive impact of warrants.

## SEC filing metadata
- accession: 0001104659-24-064883
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924064883/0001104659-24-064883-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924064883/tm2415396d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-064883
- JSON: https://secwatch.observer/filing/0001104659-24-064883.json
- Plain text: https://secwatch.observer/filing/0001104659-24-064883.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.